Resources

News

Choosing Between Immunoassays and Molecular Assays

Immunoassays and molecular assays are two distinct diagnostic tests used in healthcare and research, each with unique characteristics and applications. Immunoassays are widely used in clinical diagnostics, disease monitoring, and drug testing. They are employed to measure specific proteins or antigens. On the other hand, molecular assays are vital for genetic testing, pathogen detection, and…
Read More

Osteoinductive & Osteoconductive Biomaterials for Bone Defects: Insights into In Vitro Evaluation

Osteoinductive & osteoconductive biomaterials now play a crucial role in the treatment of traumatic, developmental, and pathological bone defects. Their purpose is to substitute or repair damaged bone. These biomaterials can be permanent or temporary and come in various forms, both natural (e.g., allografts and xenografts) and synthetic (e.g., alloplasts, metals, ceramics, polymers, and composites).…
Read More

Cytotoxicity and Cell Viability: The Big Picture

Determining cytotoxicity is a critical step in assessing the biocompatibility of medical devices, biomaterials, and drug screening. There are a wide variety of methods available to researchers; however, too often cell-based assay results indicating poor cell health without greater context slow down or halt progress on the development of a medical device. Technology is constantly…
Read More

What’s the Real Cost of Pre-Clinical Research Delays?

Ensuring that new products get to market is a top priority for R&D teams, as delays can significantly impact ROI. But the actual cost of pre-clinical research delays comes from studies that must be repeated due to incorrect testing. iFyber President, Greg Mouchka, offers insights on how to avoid these expensive mistakes. Challenges in Pre-Clinical…
Read More